XML 31 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Common Stock
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Common Stock

Note 8. Common Stock

Public Offerings of Common Stock

The following table summarizes the cumulative total shares issued, net proceeds received, and weighted average offering price in public offerings of the Company’s common stock since the IPO in June 2011.

Period

 

Cumulative Number of Shares

 

 

Cumulative Gross Proceeds

 

 

Cumulative Underwriting Fees and Commissions and Offering Costs (1)

 

 

Weighted Average Offering Price

 

Cumulative since IPO

 

 

14,388,414

 

 

$

236,597

 

 

$

8,989

 

 

$

16.44

 

(1) Fidus Investment Advisors, LLC agreed to bear a cumulative of $1,925 of underwriting fees and commissions and offering costs associated with these offerings (such amounts are not included in the number reported above). All such payments made by Fidus Investment Advisors, LLC are not subject to reimbursement by the Company.

Equity ATM Program

 

On November 10, 2022, the Company established the at-the-market program (the “ATM Program”), pursuant to which the Company may offer and sell, from time to time through Raymond James & Associates, Inc. and B. Riley Securities, Inc., each as sales agents, shares of the Company’s common stock having an aggregate offering price of up to $50,000. No shares were issued under the ATM program for years ended December 31, 2021 and 2020. The gross proceeds raised, the related sales agent commission and the offering expenses, the net proceeds raised, and the average price at which shares were issued under the ATM Program for the year ended December 31, 2022 are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales Agent

 

 

 

 

 

 

 

 

 

Gross

 

 

Commissions

 

 

Weighted-

 

 

 

Number of

 

 

Proceeds

 

 

and Offering

 

 

Average

 

Year Ended December 31, 2022:

 

Shares Sold

 

 

Received

 

 

Costs

 

 

Price

 

January 1, 2022 through March 31, 2022

 

 

-

 

 

$

-

 

 

$

-

 

 

$

-

 

April 1, 2022 through June 30, 2022

 

 

-

 

 

 

-

 

 

 

 

 

 

-

 

July 1, 2022 through September 30, 2022

 

 

-

 

 

 

-

 

 

 

 

 

 

-

 

October 1, 2022 through December 31, 2022(1)

 

 

290,388

 

 

 

5,900

 

 

 

89

 

 

 

20.32

 

Total

 

 

290,388

 

 

$

5,900

 

 

$

89

 

 

$

20.32

 

(1) Net proceeds of $5,811 were received for the period October 1, 2022 through December 31, 2022.

As of December 31, 2022, the Company has $44,100 available under the ATM Program. No shares were issued during the years ended December 31, 2021 and 2020.

Stock Repurchase Program

As described in Note 2, the Company has a Stock Repurchase Program under which the Company may acquire up to $5,000 of its outstanding common stock. The Company did not make any repurchases of common stock during the years ended December 31, 2022 and 2021. During the year ended December 31, 2020, the Company repurchased 25,719 shares of common stock on the open market for $268. The Company’s NAV per share increased by approximately $0.01 for the year ended December 31, 2020 as a result of the share repurchases. The following table summarizes the Company’s share repurchases under the Stock Repurchase Program for the years ended December 31, 2022, 2021, and 2020:

 

 

 

Years Ended December 31,

 

Repurchases of Common Stock

 

2022

 

 

 

2021

 

 

 

2020

 

Number of shares repurchased

 

 

—

 

 

 

 

—

 

 

 

 

25,719

 

Cost of shares repurchased, including commissions

$

 

—

 

 

$

 

—

 

 

$

 

268

 

Weighted average price per share

$

 

—

 

 

$

 

—

 

 

$

 

10.37

 

Weighted average discount to net asset value at quarter end prior to repurchases

 

N/A

 

 

 

N/A

 

 

 

 

38.5

%

 

Refer to Note 9 for additional information regarding the issuance of shares under the DRIP.

The Company had 24,727,788 and 24,437,400 shares of common stock outstanding as of December 31, 2022 and 2021, respectively.